Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

53.00
Delayed Data
As of 1:30pm ET
 -0.19 / -0.36%
Today’s Change
28.20
Today|||52-Week Range
73.47
-22.18%
Year-to-Date
No recent news for Prothena Corporation PLC.

Today’s Trading

Previous close53.19
Today’s open52.98
Day’s range52.04 - 54.12
Volume202,513
Average volume (3 months)383,389
Market cap$1.9B
Dividend yield--
Data as of 1:30pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-817.24%
Earnings growth (this year)-63.78%
Earnings growth (next 5 years)-2.16%
Revenue growth (last year)-96.84%
P/E ratioNM
Price/Sales1,285.33
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...-0.12-0.35%
AGIOAgios Pharmaceutical...-0.22-0.47%
HCMHutchison China Medi...-0.79-5.34%
SAGESAGE Therapeutics In...-0.98-1.88%
Data as of 1:48pm ET, 12/08/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.6M
Annual profit (last year)-$80.6M
Net profit margin-5,016.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Financial Officer &
Head-Investor Relations
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts


Search for Jobs